Gilead Sciences (GILD) Assets (2009 - 2026)
Gilead Sciences (GILD) recorded Assets of $49.36 billion in Q2 2026, down 11.4% from $55.72 billion a year earlier and down 12.3% from the prior quarter.
Powered by 
Analysis
Gilead Sciences (GILD) Assets (2009 - 2026) Analysis & Trends
At the end of FY2025, Gilead Sciences reported Assets of $59.02 billion, unchanged from FY2024.
- Annual Assets has a five-year compound annual growth rate of -2.9% (FY2020 to FY2025).
- Across earlier years, Assets came in at $59 billion in FY2024 (-5.0%), $62.13 billion in FY2023 (-1.7%), $63.17 billion in FY2022 (-7.0%) and $67.95 billion in FY2021 (-0.7%).
- The Q2 2026 figure is the lowest quarterly Assets since Q1 2016.
- On a year-over-year basis, Assets rose in three of the last eight quarters, with an average decline of 2.2%.
- Peak year-over-year performance for Assets in the last five years was growth of 10.2% in Q3 2021, against a decline of 14.0% in Q2 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $56.28 billion (Q1 2026), $59.02 billion (Q4 2025) and $58.53 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Bristol Myers Squibb | 130.49 Bn | 81.76 Bn | 9.25 Bn | 87.63 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 49.36 Bn |
| Mar 31, 2026 | 56.28 Bn |
| Dec 31, 2025 | 59.02 Bn |
| Sep 30, 2025 | 58.53 Bn |
| Jun 30, 2025 | 55.72 Bn |
| Mar 31, 2025 | 56.43 Bn |
| Dec 31, 2024 | 59.00 Bn |
| Sep 30, 2024 | 54.53 Bn |
| Jun 30, 2024 | 53.58 Bn |
| Mar 31, 2024 | 56.29 Bn |
| Dec 31, 2023 | 62.13 Bn |
| Sep 30, 2023 | 62.37 Bn |
| Jun 30, 2023 | 62.34 Bn |
| Mar 31, 2023 | 61.88 Bn |
| Dec 31, 2022 | 63.17 Bn |
| Sep 30, 2022 | 62.56 Bn |
| Jun 30, 2022 | 62.87 Bn |
| Mar 31, 2022 | 63.08 Bn |
| Dec 31, 2021 | 67.95 Bn |
| Sep 30, 2021 | 67.10 Bn |
API Access
Gilead Sciences Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();